The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

lifeminetx.com

Founded Year

2016

Stage

Series C | Alive

Total Raised

$300.07M

Last Raised

$175M | 2 mos ago

About LifeMine Therapeutics

LifeMine Therapeutics develops a genomically-enabled drug discovery approach that integrates advanced life science and computational technologies to elucidate human biology and create therapeutics that attack the fundamental drivers of serious human diseases. LifeMine accesses new drug modalities by conducting industrial-scale operation exploiting small molecule evolution in fungi to discover therapeutics. The initial focus will be on immune modulators, metabolic effectors, and cell differentiators.

LifeMine Therapeutics Headquarter Location

Cambridge Discovery Park 30 Acorn Park Drive

Cambridge, Massachusetts, 02140,

United States

617-665-5000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LifeMine Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LifeMine Therapeutics is included in 2 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

8,693 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

B

Biopharma Tech

838 items

LifeMine Therapeutics Patents

LifeMine Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Molecular biology
  • Monoclonal antibodies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/14/2018

Monoclonal antibodies, Molecular biology, Proteins, Clusters of differentiation, Streptomyces

Application

Application Date

9/14/2018

Grant Date

Title

Related Topics

Monoclonal antibodies, Molecular biology, Proteins, Clusters of differentiation, Streptomyces

Status

Application

Latest LifeMine Therapeutics News

LifeMine Therapeutics and GSK Enter Drug Discovery and Development Alliance

Mar 28, 2022

Collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules Potential to identify novel product candidates to modulate difficult-to-drug targets across multiple disease areas CAMBRIDGE, MASS –LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced a strategic R&D […]

LifeMine Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

LifeMine Therapeutics Rank

You May Also Like

P
Proteorex Therapeutics

Proteorex Therapeutics aims to discover therapeutics for diseases using a small-molecule drug discovery platform that integrates a synthesis design strategy, computational modeling, and patient-derived cell-based screening.

P
PharmCADD

PharmCADD develops Pharmulator, a computer-aided drug discovery and development platform that utilizes computational science methodologies, advanced machine learning technologies, and molecular dynamics.

C
Cloud Pharmaceuticals

Cloud Pharmaceuticals, formerly TeraDiscoveries, is a leader in the computational design of new drugs and subsequent rapid, information-driven drug development. The company accelerates the drug discovery and design process in a way that delivers tangible results and true value for partners.

B
BioSolveIT

BioSolveIT visualizes drug discovery. Its software enables every chemist to advance their research. Perceptive visualization helps the users to understand computational results at a glance.

M
Modulus Discovery

Modulus Discovery is a preclinical-stage technology-driven drug discovery company dedicated to accelerating the discovery of new medicines for patients and their families through the synthesis of computational intelligence, biological inspiration, and global integration. The company is focused on the rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its computational drug discovery expertise and biology insights.

PharmEnable Logo
PharmEnable

PharmEnable is a drug discovery company that uses a combination of medicinal chemistry and AI computational approaches to design small molecule drugs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.